# Michael Chang

> Michael Chang is a startup investor at Vivo Capital (San Francisco). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Vivo Capital](https://shizune.co/investors/profile/vivo-capital)
- Location: San Francisco, United States
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/michael-chang-7b9a931

Michael Chang is a startup investor at Vivo Capital in San Francisco. Michael Chang, M.B.A., is a Partner of Vivo Capital who invests in private and public biopharmaceutical and medical device companies. He joined Vivo with a background in healthcare strategy and operations from his prior experiences of working at Johnson & Johnson in the strategy and commercial planning function, and as a strategy consultantfor both Booz & Company and Fletcher Spaght. Mr. Chang is a co-founder of a vascular access company. Mr. Chang received his B.A. in Economics, with a focus on health policy from Harvard University, and earned his M.B.A. from Harvard Business School. He conducted extensive research on brain tumors at Harvard Medical School and on cancer genetics at the University of California, Irvine.

## About Vivo Capital

VC Fund · Palo Alto, United States

The firm is a 25-year-old global investment firm focused on healthcare with approximately $5.8 billion in AUM, which we have invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with offices in Asia. Our team consists of 50 multi-disciplinary professionals, including, physicians, scientists,entrepreneurs, operating executives, and industry experts. The firm operates as a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.

5 contacts available at Vivo Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Gaurav Aggarwal | Managing Director | https://shizune.co/investors/profile/gaurav-aggarwal |
| Mahendra G. Shah | Managing Director | https://shizune.co/investors/profile/mahendra-g-shah |
| Michael Chang | Managing Partner | https://shizune.co/investors/profile/michael-chang-2 |
| Shan Fu | Managing Partner, Co-CEO, and CEO of Asia Pacific | https://shizune.co/investors/profile/shan-fu |
| Chloe Zhang | Principal | https://shizune.co/investors/profile/chloe-zhang-1 |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co